SQUAMOUS CELL CARCINOMA OF HEAD AND NECK (SCCHN)
Clinical trials for SQUAMOUS CELL CARCINOMA OF HEAD AND NECK (SCCHN) explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF HEAD AND NECK (SCCHN) trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF HEAD AND NECK (SCCHN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat head and neck cancer: combo therapy aims to shrink tumors
Disease control Not yet recruitingThis study tests whether adding a new drug (ficerafusp alfa) to an existing immunotherapy (nivolumab) can shrink tumors better than nivolumab alone in people with advanced head and neck cancer that stopped responding to platinum chemotherapy. About 131 adults aged 18-75 will part…
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK (SCCHN)
Phase: PHASE2 • Sponsor: Groupe Oncologie Radiotherapie Tete et Cou • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
New program aims to speed up cancer care for ER patients
Knowledge-focused Not yet recruitingThis study tests a program where trained community health workers help head and neck cancer patients who first went to the emergency room. The workers call or text patients to solve problems like transportation or insurance that can delay care. The goal is to see if this support …
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK (SCCHN)
Phase: NA • Sponsor: University of Tennessee • Aim: Knowledge-focused
Last updated May 17, 2026 11:53 UTC